Home → News → Clinical Trials → Archive

Clinical Trial News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

April 2011

April 1

Medivir: Week 24 Interim Results From TMC435 Hepatitis C Phase 2b ASPIRE Study Presented at EASL Pfizer Oncology To Present Broad Array Of New Pre-Clinical And Clinical Data From Early And Late Stage Compounds Omeros Reports Outcome of Phase 3 Trials of OMS103HP Sunshine Biopharma to Appear at American Association for Cancer Research Meeting Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson's Disease to be Presented at the American Academy of Neurology Conference Positive Phase 2 Results Reported with Boehringer Ingelheim's Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients Array BioPharma Announces Five Abstracts Selected for Presentation at 2011 AACR Annual Meeting Genetic Defect Suggests High Blood Pressure May Come From Mom Neogenix Oncology to Present Data on Its Novel Antibody, NEO-201 at AACR's 2011 Annual Symposium Neogenix Oncology Novel Therapeutic Antibody, NEO-101 (Ensituximab) Data to Be Presented at AACR's 2011 Annual Symposium First Vaccine for Viral Hepatitis C Could Become a Reality Long-Term Data on QNEXA to be Presented at The American College of Cardiology Annual Meeting ArQule Announces Presentations at AACR 102nd Annual Meeting New preclinical study with Alpharadin in breast cancer models to be presented at 2011 American Association for Cancer Research Biolex's Locteron Reduces Depression Rates for HCV Patients in Phase 2b Study

April 4

NanoViricides Reports FluCide Drug Candidates Found to Offer Significant Protection Against Devastating Lung Lesions in Lethal Influenza Infection Animal Study Salix Reviews the International Liver Congress 2011 Of the European Association for the Study of the Liver Weight Loss With QNEXA Over Two Years Provides Patients With Substantial Cardiovascular Benefits Synta Announces Ganetespib Results at AACR ? Inhibition of Multiple Oncogenes and Resistance Mechanisms Leads to Potent Activity in NSCLC and Strong Enhancement of Radiation Therapy Livatag (Doxorubicin Transdrug?) follow up demonstrates significant survival increase in advanced hepatocellular carcinoma patients Two Sets of Genes Predict Response to Lung Cancer Drug New Data Analyses with Victrelis (boceprevir), Merck's Investigational Medicine, Examined Possible Predictors of Sustained Virologic Response Synta Announces Results Presented at AACR Further Elucidate Mechanism by Which Elesclomol Targets Cancer Cell Metabolism Orexigen Therapeutics Presents Additional Contrave Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring Idera Pharmaceuticals Presents Data from a Multiple-Dose Phase 1 Clinical Trial of IMO-3100, Lead Drug Candidate for the Treatment of Autoimmune Diseases Antidepressants Linked To Thicker Arteries Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data From Phase 2 Study of ABT-450/r for Treatment of Hepatitis C Curis Announces Investigator-Initiated Phase II Study Results Presented at 102nd AACR Annual Meeting 2011 Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results Cerulean Pharma Inc. Presents Phase 2a Clinical Data at American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation Treatments Show Promise in Reducing Autism-Related Behaviors, But Some Have Significant Side Effects ExonHit Announces Publication of EHT 0202 Phase IIa Results in Current Alzheimer Research BIOTRONIK Announces Positive 6-month Results for Pantera Lux Paclitaxel Releasing Balloon Medtronic Resolute Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies Aeterna Zentaris Announces Results On Its Lead Anticancer Agent Perifosine at American Association for Cancer Research Annual Meeting OncoGenex Announces Data Highlighting OGX-427 at American Association of Cancer Research (AACR) 102nd Annual Meeting 2011 Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session Boston Scientific's Promus Element Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial SCAI Statement on "The RIVAL Trial: A Randomized Comparison of Radial Versus Femoral Access for Coronary Angiography or Intervention in Patients With Acute Coronary Syndromes" Revalesio Presents Multiple Sclerosis and Alzheimer's Disease Research at National Neurology Conference Cancer Treatment Breakthrough Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas Stealth Peptides Inc. Announces Results from Healthy Volunteers Phase I Clinical Study with Bendavia ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkin's Lymphoma Cytotech Labs Unravels Hallmark Insight Into Metabolic Control of Cancer, Presents Work at Major AACR Cancer Meeting Oncothyreon Presents Preclinical Data for ONT-10 and PX-866 at American Association for Cancer Research Nanopolymer shows promise for helping reduce cancer side effects NIH Study Finds Genetic Clues To Major Cause Of Kidney Disease Worldwide

April 5

CEO of ARCA biopharma to Present at American College of Cardiology 60th Annual Scientific Session and i2 Summit 2011 Large Weight Gain Raises Risk for Recurrence Among Breast Cancer Survivors Aeterna Zentaris Announces Results on AEZS-131, a Highly Selective Erk 1/2 Inhibitor Anticancer Compound at American Association for Cancer Research Annual Meeting Peregrine's PS-Targeting Antibody Significantly Improves Anti-Tumor Effect of Sorafenib in Models of Advanced Liver Cancer Basilea Pharmaceutica AG (CH) - New research data highlight the potential of Basilea's BAL101553 as a novel oncology drug candidate Seattle Genetics Highlights ADC Technology Research at AACR Neurotech's NT-501 Implant Slows Vision Loss in Patients with Geographic Atrophy Associated with Dry AMD as Reported in PNAS Aeterna Zentaris Announces Results on AEZS-131, a Highly Selective Erk 1/2 Inhibitor Anticancer Compound at American Association for Cancer Research Annual Meeting ARIAD Presents New Preclinical Data on Ponatinib in Solid Tumors, Demonstrating Inhibition of All FGF Receptor Kinases Acceleron Presents Positive Results from Phase 1 Study of ACE-041 in Patients with Advanced Cancer Peregrine Presents Phase Ib HCV/HIV Data on Single-Agent Bavituximab at EASL Data from Two Mipomersen Phase 3 Trials Presented at ACC Chest Pain Med Is Effective For Refractory Angina, But Adherence Problematic New Study Results Presented on Dexlansoprazole and Lansoprazole Effects on Plavix (clopidogrel bisulfate) Cardio3 BioSciences Announces Results of the C-Cure Phase II Clinical Trial at the 60th Annual American College of Cardiology Meeting Phase 1 Data on MM-121 Will Be Presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) In Study of Acutely Ill Patients Rivaroxaban Compares Favorably With Enoxaparin in Preventing Venous Thromboembolism but With an Increased Rate of Bleeding Keryx Biopharmaceuticals Announces Results on KRX-0401 (Perifosine) at American Association for Cancer Research Annual Meeting Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor Tolerx Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses Karmanos Scientists Explore Role of Tumor Suppressor Gene in Inhibiting Prostate Cancer Cell Metastasis Celldex to Present Data for Novel Immunotherapy Antibody Program at 102nd Annual AACR Meeting Phase 3 MARINE Trial Data to be Presented in May at the National Lipid Association 2011 Annual Scientific Sessions BiTE Antibody MT112/BAY 2010112 Demonstrates Potent Activity against Human Prostate Cancer Cells Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA, TLK199) Analogs at American Association for Cancer Research Annual Meeting Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors CT Atlantic AG to Present Positive Preclinical Results for NY-ESO-1 HD-MAB at Forthcoming AACR Annual Meeting

April 6

Tetraphase to Present at Cambridge Health Institute's Antibacterial Drug Development Conference Seattle Genetics Reports Brentuximab Vedotin (SGN-35) Data at EBMT Annual Meeting Teva and OncoGenex Present Preclinical Data on the Activity of its Antisense Compound Custirsen (OGX-011/TV-1011) at the American Association of Cancer Research (AACR) Annual Meeting 2011 Federal Research Team at DMC/WSU Publishes Major International Study Documenting Breakthrough in Preventing Premature Birth Neuralstem ALS Trial in Multiple Presentations at Upcoming American Academy of Neurology Meeting Novel Drug Produces Negative Results in Reducing Heart Injury After Blocked Arteries Are Opened Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE Vaginal Progesterone Gel Study Results VBL Therapeutics Presents Two Studies on VB-111 at 102nd Annual AACR Meeting Curis Presentations Highlight Breadth of Targeted Cancer Platform at 102nd AACR Annual Meeting 2011 Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting Avila Therapeutics Announces Positive Clinical Data for Btk Inhibitor, AVL-292, in Phase 1a Studies Circadian's VGX-100 Inhibits Tumour Growth in Models of Lung, Ovarian and Prostate Cancer Jennerex and Transgene Announce Presentation of Phase 1 Data Demonstrating that JX-594 Administration Targets Tumor Vasculature Cannabis Science Provides Physician's Documentation That Confirms Successful Treatment of Skin Cancer

April 8

Transcriptional Silencing of ASS1 Suggests the Potential Use of ADI-PEG 20 to Treat AML, Glioblastoma and Bladder Cancer Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting EMD Serono's Commitment to Advance Multiple Sclerosis Care and Research Underscored by Data to Be Presented at AAN 2011 Meeting Targacept Presents Statistically Significant Results for TC-5619 on Measures of Cognitive Dysfunction in Schizophrenia and Negative Symptoms of Schizophrenia T-DM1 Significantly Improved Progression-Free Survival in Randomized Phase II Trial Roche Announces Positive Phase II Results for Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress Generex Oral-lyn Data to be Presented at Two International Scientific Symposia Digestive Experts Grade Treatment Options for Inflammatory Bowel Disease Outsmarting Cancer Cells: Researchers Learn How They Spread The American Academy of Anti-Aging Medicine Not Surprised by Study Showing Estrogen Lowers Breast Cancer Risk In Women

April 11

Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIMETHYL FUMARATE) in Multiple Sclerosis Pfizer and Medivation Announce Results From Phase 3 Horizon Trial of Dimebon in Huntington Disease Novartis Discontinues Clinical Trial of Tasigna for Investigational Use in Newly Diagnosed Patients With Unresectable and/Or Metastatic GIST PROLOR Biotech Announces Positive Interim Results From Phase II Trial of its Long-Acting Human Growth Hormone Cytokinetics Announces Data From Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis to Be Presented at the 63rd Annual Meeting of the American Academy of Neurology Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History Or Disease Severity, New Analysis Shows New STEDESA Clinical Data Presented at American Academy of Neurology Annual Meeting Acorda Therapeutics Presents New AMPYRA (dalfampridine) Data Analyses on Walking Improvement in Multiple Sclerosis at AAN Annual Meeting Update on Phase II/III Clinical Trial of Investigational Staphylococcus Aureus Vaccine, V710 Teva Announces Presentation of New Data on Multiple Sclerosis and Parkinson's Disease Treatments at 2011 American Academy of Neurology Annual Meeting VIVITROL to be Featured in Data Presentations at American Society of Addiction Medicine Conference Fatigue and Sleep Woes Worsen Neurocognitive Problems in Childhood Cancer Survivors Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy Fragment of RegeneRx?s T?4 Inhibits Activation of Liver Cells Responsible Fibrosis & Scar Formation Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment Acorda Therapeutics Presents New Ampyra (dalfampridine) Data Analyses on Walking Improvement in Multiple Sclerosis at AAN Annual Meeting

April 12

Durect Announces Eladur (TRANSDUR-Bupivacaine) Phase II Study Results in Chronic Low Back Pain MAP Pharmaceuticals to Present Data From Levadex Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology First Clinical Trial of Gene Therapy for Pain Reported by U-M Neurologists QNEXA Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities Phase I Research of Extended-Release Topiramate Shows Less Fluctuation in Plasma Levels Breakthrough Cholesterol-Lowering Treatment Detailed in Study Published in Neuroendocrinology Letters Evidence Lacking for Efficacy of Memantine in Treating Mild Alzheimer Disease Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability Investigational Drug May Reduce Involuntary Movements in People With Parkinson's Disease

April 18

Nabriva Reports Positive Results from Phase II Trial of Pleuromutilin Antibiotic BC-3781 in ABSSSI Idera Pharmaceuticals Publishes Data Demonstrating Novel Gene-silencing Oligonucleotide (GSO) Technology Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C Nabriva Reports Positive Results from Phase II Trial of Pleuromutilin Antibiotic BC-3781 in ABSSSI - First proof of concept forsystemic use of this new class of antibiotics in man CytRx Announces the Publication of a Peer-Reviewed Case Report Documenting Tamibarotene's Successful Elimination of Recurrent Advanced-Stage Leukemia Scripps Research Scientists Develop Compound That Effectively Halts Progression of Multiple Sclerosis Anacor Pharmaceuticals to Present New Data on AN2728 and GSK ?052 at Upcoming Meetings Advaxis Lead Drug ADXS11-001 Well-Tolerated in 72 Patients, to Date Study Finds Letter to Health Care Providers Results in Reduction of Potentially Unsafe Concurrent Use of Plavix and Proton Pump Inhibitors YM BioSciences Reports Positive Updated Anemia Response Data for its JAK1/JAK2 Inhibitor CYT387 Disclosed at First Annual Florence Meeting on Myeloproliferative Neoplasms in Florence, Italy

April 26

April 28

Shire Reports Positive Results From Signal Finding Study of Investigative Use of Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) as Adjunctive Treatment in Predominant Negative Symptom Schizophrenia Data on Vivitrol, the New FDA-Approved Medication for Prevention of Relapse to Opioid Dependence, Published in the Lancet Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis PolyMedix Defensin-Mimetic Antibiotic PMX-30063 Active Against NDM-1 Drug-Resistant Bacteria Study Targets Treatment for Serious ACE Inhibitor Side Effect Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 13th International Myeloma Workshop Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration Data Published in Blood Demonstrate Potent Activity of MacroGenics' Proprietary DART Technology RIKEN: New Study Sheds Light on Evolution of 2009 Pandemic Influenza A(H1N1) Virus in Japan Regulus Therapeutics and Collaborators Present New Results from Preclinical Research on microRNA Therapeutics in Metabolic Disease Otonomy Announces Positive Results from Phase 1b Study of OTO-104 in Meniere's Disease Metabolomics Insight into Desiccation Tolerance in Plants Published in The Plant Cell Positive Clinical Data for Otonomy's OTO-104 in Debilitating Ear Disorder QLT Announces QLT091001 Presentation At ARVO

Clinical Trial Results Archive

2005

April

More News Resources

(web2)